Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test

Neuroscience

Volumn 88, Issue 2, 1999, Pages 609-615

  Espejo, E F ^a   Minano F J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

6 OHDA; Depression; Desipramine; Dopamine; Forced swimming test; Medial prefrontal cortex

Indexed keywords

DESIPRAMINE;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; MALE; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DEPRESSION; DESIPRAMINE; DOPAMINE; MALE; NOREPINEPHRINE; OXIDOPAMINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN; SWIMMING; SYMPATHOLYTICS;

EID: 0344906262     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00258-9     Document Type: Article

References (21)

1. Baxter L. R., Schwartz J. M., Phelps M. E., Mazziota J. C., Guze B. H., Selin C. F., Gerner R. H., Sumida R. M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archs gen. Psychiat. 46:1989;243-254.
2. Bean A. J., Roth R. H. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions. Brain Res. 549:1991;155-158.
3. Björklund A. and Lindvall A. (1984) Dopamine-containing systems in the CNS. In Handbook of Chemical Neuroanatomy (eds Björklund A. and Hökfelt T.), Vol. 2, pp. 55-112. Elsevier, Amsterdam.
4. 18F]2-deoxyglucose in affective illness. J. Affect. Disord. 10:1986;137-145.
5. Carboni E., Tanda G. L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55:1990;1067-1070.
6. Carter C. J., Pycock C. J. Studies on the role of catecholamines in lesions of the frontal cortex of the rat: changes in neurotransmitter systems in subcortical region. Br. J. Pharmac. 64:1978;430.
7. Carter C. J., Pycock C. J. Behavioral and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 192:1980;163-176.
8. Detke M. J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test diferentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121:1995;66-72.
9. Galey D., Simon H., Le Moal M. Behavioral effects of lesions in the A10 dopaminergic area of the rat. Brain Res. 124:1977;83-97.
10. Heffner T. G., Hartman J. A., Seiden L. S. A rapid method for the regional dissection of the rat brain. Pharmac. Biochem. Behav. 13:1980;453-456.
11. Jordan S., Kramer G. L., Zukas P. K., Petty F. Previous stress increases in vivo biogenic amine response to swim stress. Neurochem. Res. 19:1994;1521-1525.
12. Lemberger L., Fuller R. W., Zerbe R. L. Use of specific serotonin uptake inhibitors as antidepressants. Clin. Neuropharmac. 8:1985;299-317.
13. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
14. Maes M., Maes L., Suy E. Symptom profiles of biological markers in depression: a multivariate study. Psychoneuroendocrinology. 15:1990;29-37.
15. Nelson J., Bowers M., Sweeney D. Exacerbation of psychosis by tricyclic antidepressants in delusional depression. Am. J. Psychiat. 136:1979;574-576.
16. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, San Diego.
17. Porsolt R. D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
18. Shatzberg A. F., Rothschild A. J., Langlais P. J., Bird E. D., Cole J. O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiat. 19:1985;57-64.
19. Slater P. J. B. (1978) Data collection. In Quantitative Ethology (ed. Colgan P. W.), pp. 7-24. Wiley, New York.
20. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology. 115:1994;285-288.
21. Thiebot M. H. and Martin P. (1991) Effects of benzodiazepines, 5-HT1A agonists and 5-HT3 antagonists in animal models sensitive to antidepressant drugs. In 5-HT1A Agonists, 5-HT3 Antagonists and Benzodiazepines. Their Comparative Pharmacology (eds Rodgers R. J. and Cooper S. J.), pp. 159-195. Wiley, New York.